GABAA受容体
注

↑  Richter L, de Graaf C, Sieghart W, Varagic Z, Mörzinger M, de Esch IJ, Ecker GF, Ernst M (March 2012). “Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands”. Nat. Chem. Biol. 8 (5):  455–464. doi:10.1038/nchembio.917. PMC 3368153. PMID 22446838. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368153/.
↑  Campagna-Slater V, Weaver DF (January 2007). “Molecular modelling of the GABAA ion channel protein”. J. Mol. Graph. Model. 25 (5):  721–30. doi:10.1016/j.jmgm.2006.06.001. PMID 16877018.
↑  Sancar F, Ericksen SS, Kucken AM, Teissére JA, Czajkowski C (January 2007). “Structural Determinants for High-Affinity Zolpidem Binding to GABA-A receptors”. Mol. Pharmacol. 71 (1):  38–46. doi:10.1124/mol.106.029595. PMC 2583146. PMID 17012619. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583146/.
↑  Santhakumar V, Wallner M, Otis TS (May 2007). “Ethanol acts directly on extrasynaptic subtypes of GABAA receptors to increase tonic inhibition”. Alcohol 41 (3):  211–21. doi:10.1016/j.alcohol.2007.04.011. PMC 2040048. PMID 17591544. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040048/.
↑  Johnston GAR (1996). “GABAA Receptor Pharmacology”. Pharmacology and Therapeutics 69 (3):  173–198. doi:10.1016/0163-7258(95)02043-8. PMID 8783370.
1 2 3 4 5 6 7 8 9  石郷岡純 2009.
↑  Olsen RW, Sieghart W (2008). “International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update.”. Pharmacological Reviews 60 (3):  243–260. doi:10.1124/pr.108.00505. PMID 18790874.
1 2 3  碓氷章 2009.
↑  Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1 June 1998). “International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function”. Pharmacol. Rev. 50 (2):  291–313. PMID 9647870. http://pharmrev.aspetjournals.org/cgi/content/abstract/50/2/291.
↑  “Overdose Facts & Stats”.   International Overdose Awareness Day. 2014年1月20日閲覧。
↑  “GABA(A) receptor activation and open-channel block by volatile anaesthetics: a new principle of receptor modulation?”. European Journal of Pharmacology 451 (1):  43–50. (September 2002). doi:10.1016/S0014-2999(02)02194-5. PMID 12223227.
1 2  “Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro”. The Journal of Physiology 539 (Pt 1):  191–200. (February 2002). doi:10.1113/jphysiol.2001.013147. PMC 2290126. PMID 11850512. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2290126/.
1 2  “Taurine and beta-alanine act on both GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA”. Brain Research 464 (2):  97–105. (September 1988). doi:10.1016/0169-328x(88)90002-2. PMID 2464409.
↑  Hunter, A (2006). “Kava (Piper methysticum) back in circulation”. Australian Centre for Complementary Medicine 25 (7):  529.
1 2  (a) “Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors”. Pharmacology & Therapeutics 116 (1):  20–34. (October 2007). arXiv:1607.02870. doi:10.1016/j.pharmthera.2007.03.007. PMID 17531325. http://www.journals.elsevier.com/pharmacology-and-therapeutics. ; (b) “Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites”. Nature 444 (7118):  486–489. (November 2006). Bibcode: 2006Natur.444..486H. doi:10.1038/nature05324. PMID 17108970. ; (c)“Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis”. Proceedings of the National Academy of Sciences of the United States of America 103 (39):  14602–14607. (September 2006). Bibcode: 2006PNAS..10314602A. doi:10.1073/pnas.0606544103. PMC 1600006. PMID 16984997. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1600006/. ; (d) “Neurosteroid access to the GABAA receptor”. The Journal of Neuroscience 25 (50):  11605–11613. (December 2005). doi:10.1523/JNEUROSCI.4173-05.2005. PMC 6726021. PMID 16354918. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726021/. ; (e) “Neurosteroids: endogenous regulators of the GABA(A) receptor”. Nature Reviews. Neuroscience 6 (7):  565–575. (July 2005). doi:10.1038/nrn1703. PMID 15959466. ; (f) “Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake”. Psychopharmacology 186 (3):  362–372. (June 2006). doi:10.1007/s00213-005-0213-2. PMID 16432684. ; (g) “Steroids, neuroactive steroids and neurosteroids in psychopathology”. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 (2):  169–192. (February 2005). doi:10.1016/j.pnpbp.2004.11.001. PMID 15694225. ; (h) “Neurosteroids: biochemistry and clinical significance”. Trends in Endocrinology and Metabolism 13 (1):  35–43. (2002). doi:10.1016/S1043-2760(01)00503-3. PMID 11750861. ; (i) “Neurosteroids act on recombinant human GABAA receptors”. Neuron 4 (5):  759–765. (May 1990). doi:10.1016/0896-6273(90)90202-Q. PMID 2160838. ; (j) “Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor”. Science 232 (4753):  1004–1007. (May 1986). Bibcode: 1986Sci...232.1004D. doi:10.1126/science.2422758. PMID 2422758. https://zenodo.org/record/1230988. ; (k) “Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy”. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US). National Center for Biotechnology Information (US). (2012). https://www.ncbi.nlm.nih.gov/books/NBK98218/
↑  “STUDY OF GABAERGIC AGONISTS”. Deccan Journal of Pharmacology 1 (2):  56–69. (2010).  オリジナルの2013-10-16時点におけるアーカイブ。. https://web.archive.org/web/20131016082147/http://www.ijdpls.com/uploaded/journal_files/120402040442.pdf 2013年2月12日閲覧。.
↑  “The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator”. Neuropharmacology 56 (1):  190–197. (January 2009). doi:10.1016/j.neuropharm.2008.06.004. PMC 2665930. PMID 18585399. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665930/.
↑  “Lanthanum potentiates GABA-activated currents in rat pyramidal neurons of CA1 hippocampal field”. Bulletin of Experimental Biology and Medicine 140 (4):  403–405. (October 2005). doi:10.1007/s10517-005-0503-z. PMID 16671565.
↑  “Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function”. Neuropharmacology 42 (2):  199–209. (February 2002). doi:10.1016/s0028-3908(01)00175-7. PMID 11804616.
↑  “Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity”. Nature Neuroscience 6 (4):  362–369. (April 2003). doi:10.1038/nn1030. PMID 12640458.
↑  “The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors”. Biochemical Pharmacology. Six Decades of GABA 68 (8):  1631–8. (October 2004). doi:10.1016/j.bcp.2004.07.022. PMID 15451406.
↑  “An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition”. The Journal of Pharmacology and Experimental Therapeutics 316 (3):  1335–1345. (March 2006). doi:10.1124/jpet.105.092320. PMID 16326923. http://pdfs.semanticscholar.org/22aa/5af270a5dff6b125aadd1c231dd0bd464782.pdf.
↑  “GABA A/Bz receptor subtypes as targets for selective drugs”. Current Medicinal Chemistry 14 (25):  2680–2701. (2007). doi:10.2174/092986707782023190. PMID 17979718.
↑  “Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABA(A) receptors”. Bioorganic & Medicinal Chemistry 16 (14):  6936–6948. (July 2008). doi:10.1016/j.bmc.2008.05.049. PMID 18541432.
↑  “Paradoxical reactions to benzodiazepines in intravenous sedation: a report of 2 cases and review of the literature”. Anesthesia Progress 49 (4):  128–32. (2002). PMC 2007411. PMID 12779114. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2007411/.
↑  “Benzodiazepines and disinhibition: a review”. Psychiatric Bulletin (Royal College of Psychiatrists) 26 (12):  460–462. (2002). doi:10.1192/pb.26.12.460. ISSN 0955-6036.
↑  “Allopregnanolone and mood disorders”. Progress in Neurobiology 113:  88–94. (February 2014). doi:10.1016/j.pneurobio.2013.07.005. PMID 23978486.
↑  “General anesthesia, sleep, and coma”. The New England Journal of Medicine 363 (27):  2638–50. (December 2010). doi:10.1056/NEJMra0808281. PMC 3162622. PMID 21190458. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162622/.
GABAA受容体は、αが2個、βが2個、γが1個（図ではα1が2個、β2が2個、γ2が1個）の5個のサブユニットから成る5量体であり、GABAの結合部位や、アロステリック調節部位としてのベンゾジアゼピン結合部位が存在する。
GABAA受容体と様々なリガンドが結合する場所。